Integral Derivatives’s Aetna Inc AET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-25,962
Closed -$4.67M 1170
2017
Q4
$4.68M Buy
+25,962
New +$4.46M 0.09% 131
2017
Q3
Sell
-2,965
Closed -$463K 1357
2017
Q2
$450K Sell
2,965
-2,000
-40% -$283K 0.01% 736
2017
Q1
$633K Sell
4,965
-3,703
-43% -$465K 0.01% 668
2016
Q4
$1.07M Buy
+8,668
New +$1.04M 0.02% 489
2016
Q2
Sell
-4,654
Closed -$534K 1154
2016
Q1
$523K Sell
4,654
-5,000
-52% -$535K 0.02% 515
2015
Q4
$1.04M Buy
9,654
+5,698
+144% +$616K 0.03% 444
2015
Q3
$433K Buy
+3,956
New +$457K 0.01% 744
2015
Q2
Sell
-6,525
Closed -$745K 1337
2015
Q1
$695K Buy
6,525
+2,330
+56% +$228K 0.01% 609
2014
Q4
$373K Buy
+4,195
New +$352K 0.01% 1008

Other funds holding AET

Integral Derivatives's AET Position: Q1 2018 in Review

Integral Derivatives sold out of Aetna Inc (AET) in Q1 2018, closing a stake of 25,962 shares — an estimated $4.67M sold.

Integral Derivatives first reported a position in AET in Q4 2014 and held it in 9 quarters. The position peaked at $4.68M in Q4 2017. 1,004 funds tracked by Wall St. Rank hold AET as of Q1 2018.

  • Integral Derivatives reported no remaining Aetna Inc position as of Q1 2018 after selling out during the quarter.
  • Integral Derivatives sold 25,962 Aetna Inc shares in Q1 2018, an estimated $4.67M.
  • Integral Derivatives first reported a position in Aetna Inc in Q4 2014 and held it in 9 quarters.
  • Integral Derivatives's Aetna Inc position peaked at $4.68M in Q4 2017.
  • 1,004 funds tracked by Wall St. Rank held Aetna Inc as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.